VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, January 7, 2026
Stock Comparison
Lifco AB (publ) vs Novo Nordisk A/S
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Lifco AB (publ)
LIFCO-B · Nasdaq Stockholm
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Lifco AB (publ)'s moat claims, evidence, and risks.
View LIFCO-B analysisNovo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisComparison highlights
- Moat score gap: Novo Nordisk A/S leads (85 / 100 vs 58 / 100 for Lifco AB (publ)).
- Segment focus: Lifco AB (publ) has 3 segments (51.2% in Systems Solutions); Novo Nordisk A/S has 3 segments (71.1% in Diabetes care).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Moderate.
- Moat breadth: Lifco AB (publ) has 8 moat types across 2 domains; Novo Nordisk A/S has 5 across 3.
Primary market context
Lifco AB (publ)
Systems Solutions
Niche B2B systems solutions (contract manufacturing, environmental technology, infrastructure products, special products, transportation products)
Primarily Europe; global customers where applicable
B2B OEMs and industrial customers
Niche manufacturer and systems solution provider
51.2%
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
Side-by-side metrics
Moat coverage
Shared moat types
Lifco AB (publ) strengths
Novo Nordisk A/S strengths
Segment mix
Lifco AB (publ) segments
Full profile >Dental
Oligopoly
Demolition & Tools
Oligopoly
Systems Solutions
Competitive
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.